YELLOW FEVER
Clinical trials for YELLOW FEVER explained in plain language.
Never miss a new study
Get alerted when new YELLOW FEVER trials appear
Sign up with your email to follow new studies for YELLOW FEVER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New yellow fever shot tested in japan
⭐️ VACCINE ⭐️ CompletedThis study tested a yellow fever vaccine in healthy adults in Japan. Researchers gave a single shot to 254 participants and monitored them for one month to see if their bodies developed a strong immune response and to check for side effects. The goal was to gather safety and effe…
Matched conditions: YELLOW FEVER
Phase: PHASE3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test new shot to protect against yellow fever
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new, inactivated yellow fever vaccine in healthy adults to see if it was safe and if it could trigger a protective immune response. Twenty-six participants received either the vaccine or a placebo in two doses, one month apart. The main goal was to…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: Najit Technologies, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 27, 2026 12:38 UTC
-
Scientists test Next-Gen shot against deadly yellow fever
⭐️ VACCINE ⭐️ CompletedThis was a first-in-human safety study for a new experimental yellow fever vaccine. Researchers enrolled 92 healthy adults to test the vaccine's safety and the body's immune response to it. They compared the vaccine given with and without an extra ingredient (an adjuvant) designe…
Matched conditions: YELLOW FEVER
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 11, 2026 14:52 UTC
-
Scientists map Body's defense against yellow fever vaccine
Knowledge-focused CompletedThis study aimed to learn how the human immune system responds to the yellow fever vaccine. Researchers gave the standard yellow fever vaccine to 239 healthy adults and tracked their immune responses for up to a year. The goal was to understand what makes this vaccine so effectiv…
Matched conditions: YELLOW FEVER
Phase: PHASE4 • Sponsor: Emory University • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists probe why some vaccines Don't last
Knowledge-focused CompletedThis study aimed to understand why some people's immune systems don't build strong, lasting protection from vaccines. Researchers gave the yellow fever vaccine to 43 healthy adults in Uganda and Minnesota. They collected tissue and blood samples to see if other ongoing infections…
Matched conditions: YELLOW FEVER
Phase: PHASE1, PHASE2 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC